Paysign, Inc. (NASDAQ: PAYS) is an innovative leader in specialized payment solutions, such as prepaid card products, digital wallets, and payment processing services. Headquartered in Henderson, Nevada, Paysign offers a variety of products catering to multiple markets, such as pharmaceuticals, healthcare, incentive, and others.
The mission of Paysign is to enable its clients to engage with their consumers, employees, and vendors more effectively. They achieve this through their proprietary platform that delivers unique payment solutions easily adaptable to an individual business's specific needs.
Paysign's pharmaceutical solutions comprise co-pay assistance products, designed to mitigate out-of-pocket expenses for patients. Its feature-rich platform includes solutions such as reloadable, non-reloadable, and instant-issue prepaid cards that can be tailored to the individual requirements of business entities. These solutions serve different sectors including consumer products, corporate incentives, and healthcare reimbursements.
A critical aspect of Paysign's offerings is their robust security measures. The solutions are PCI-DSS Level 1 compliant, ensuring the highest level of security for its partnerships. This in turn boosts consumer trust in the products and services protected by Paysign. The company is committed to advancing its technology while ensuring stringent data protection and security to all stakeholders.
Paysign also provides end-to-end program management and reporting. With this, they are able to design unique solutions, implement them efficiently, and also track and report the data collected during the process. This helps businesses to have ongoing insights, supporting wise and thoughtful decision making.
As a public traded company listed on NASDAQ, Paysign, Inc (PAYS) has shown a continuous growth potential. The company has established a reputation for their nimble ability to adapt to market changes and their commitment to provide excellent customer service. Their work has been seen as a way to streamline payment processes and increase efficiency for their clients.
Paysign’s ability to integrate their platform with the existing systems of their clients, sets them apart from their competitors. This facilitates seamless transactions and offers great flexibility to businesses. Furthermore, the company is forward-thinking in its adoption and implementation of digital payment technology, thereby staying proactive in this rapidly evolving financial landscape.
In conclusion, Paysign, Inc. is a partner-of-choice for many organizations in need of niche payment solutions. Recognized for its commitment to innovation, security, and customer care, Paysign offers state-of-the-art prepaid solutions and payment processing services that are enhancing how businesses are conducting their financial operations today.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Paysign's EVP Joan Herman sold 38,900 shares of the company's stock for over $450,000 under a Rule 10b5-1 trading plan, retaining a significant stake worth approximately $7.15 million. The transaction follows a period where Paysign's stock performance has been strong, with shares rising 5.1% to $12.42, and the company exceeding quarterly EPS and revenue estimates. Analysts maintain a "Buy" rating for Paysign with a consensus target price of $14.00, reflecting confidence in its future performance.
Cunningham Bradley Kramer, Paysign Inc.'s Chief Technology Officer, has surrendered 46,378 shares of the company, with transaction prices ranging from $5.87 to $8.96. The article details Kramer's various holdings in Paysign, including distinct positions of 130,000, 30,000, 114,000, 33,334, and 66,666 shares. This surrender is part of the disclosed ownership information for Paysign (NASDAQ: PAYS).
Bank of America Corp DE significantly increased its stake in Paysign, Inc. by 345.9% in Q1, now holding 130,930 shares valued at $772,000. Despite this institutional interest, Paysign insiders have recently sold 345,000 shares worth $3.56 million. The company reported strong Q1 earnings, beating analyst estimates for both EPS and revenue, and analysts maintain a consensus "Buy" rating with an average price target of $13.33.
Paysign (NASDAQ: PAYS) is projecting revenue between $114 million and $117 million for the current year, driven by significant growth in its patient-affordability business, which is expected to reach $60 million in revenue. The company also anticipates plasma revenue to hit nearly $57 million. Paysign attributes its financial strength to operating leverage from shared infrastructure and a robust balance sheet with over $30 million in unrestricted cash and no bank debt, supporting its expansion efforts in both healthcare-focused segments.
Paysign, Inc. (PAYS) has significantly outperformed its Business Services peers and the broader sector this year, with its stock gaining 148.5% compared to the sector's average return of -8.5%. The company holds a Zacks Rank of #2 (Buy), driven by a 16% increase in its full-year earnings consensus estimate over the last quarter. Another notable outperformer in the sector is Sezzle Inc. (SEZL), which has returned 97.6% year-to-date and holds a Zacks Rank #1 (Strong Buy).
GSA Capital Partners LLP has acquired a new stake of 119,578 shares in Paysign, Inc. (NASDAQ:PAYS) during the second quarter, valued at approximately $979,000. This makes GSA Capital Partners LLP an owner of 0.21% of Paysign's stock. Other institutional investors also increased their holdings, and the article details recent financial performance, analyst ratings, and insider trading activities for Paysign.
OneDigital Investment Advisors LLC recently acquired 107,077 shares of Paysign, Inc. ($PAYS) valued at approximately $877,000, bringing institutional ownership to 25.89%. Despite recent insider stock sales by the CEO and CFO, the company reported strong Q2 earnings, exceeding analyst estimates, and analysts maintain a consensus "Buy" rating with an average price target of $13.33. Paysign, a financial technology company specializing in prepaid payment solutions, also issued positive fiscal 2026 EPS guidance.
Wall Street Zen has downgraded Paysign (NASDAQ:PAYS) from "strong-buy" to "buy," although the broader analyst consensus remains "Buy" with an average price target of $13.33. The company recently reported strong quarterly earnings, exceeding both EPS and revenue estimates, and issued positive fiscal 2026 EPS guidance. Despite these positive financial results, there have been significant insider stock sales totaling over $4 million in the past 90 days.